Anti-Aging Services Market Overview By Share, Size, Industry Players, Revenue And Product Demand Forecast Till 2023

Anti-Aging Services Market Overview

The global anti-aging services market has been likely to expand substantially during the forecast period. In 2017, the market held a worth of USD 21.39 billion in 2017. It has been estimated to develop at a 5.47% CAGR over the forecast period.

Increasing urge to remain young coupled with the growing geriatric population, are the key factors driving the development of the anti-aging services market. World Health Organization (WHO) reported that between 2015 and 2050, the proportion of the global populace above 60 years will almost double from 12% to 22%. Additionally, World Health Organization anticipated that by 2020, the number of individuals aged 60 years and above will outnumber kids younger than 5 years. Also, by 2050, 80% of older people will be residing in middle- and low-income nations. Besides, the impact of media and fashion industry, surging need for anti-aging services and drugs, soaring cognizance about the aesthetical industry, and increasing disposable income are propelling the market for anti-aging services.

However, the probable risks associated with anti-aging cures along with the rising cost of some of the procedures are the key factors that hinder the development of the anti-aging services market to some extent.

Anti-Aging Services Market Segmentation

The worldwide anti-aging services market has been segmented into service provider and type of service.

By type of service, the market has been segmented into breast augmentation, microdermabrasion, liposuction, chemical peel, sclerotherapy, intense pulsed light, Botox treatment, dermal fillers, and others. In 2017, the microdermabrasion segment has been estimated to register the largest share in the worldwide anti-aging services market. The large share has been widely credited to the surging acceptance in various regions, greater acceptance of the procedure, enhanced outcomes as compared to other services, and improved patient compliance. During the forecast period of 2018 to 2023, the liposuction segment has been anticipated to represent the second largest market.

By service providers, the market has been segmented into salons, dermatology clinics, hospitals, and others. In 2017, dermatology clinics segment recorded the biggest share in the worldwide anti-aging services market followed by hospitals segment. The key share of the dermatology clinics is mostly credited to the extended range of anti-aging services offered by such specialty clinics. 

Anti-Aging Services Market Regional Analysis

Region wise, the Americas has been estimated to lead the worldwide anti-aging services market on account of the surging disposable income, flourished healthcare infrastructure, rising adoption of the anti-aging services by the residents of the US, and improved cognizance about the body aesthetics. Additionally, the huge impact of the film and fashion sector in the US has caused augmented demand generation for the aesthetic and beauty services including the anti-aging services. The sum of all the above-mentioned factors have been playing substantial roles in encouraging the market growth in the Americas. Europe has been estimated to represent the second largest market share in the worldwide anti-aging services market. Factors like increasing demand for aesthetic cure, acceptance of anti-aging treatments, and expanding geriatric population in the region, can be considered responsible for propelling the anti-aging services market growth. The Middle East & Africa region has been estimated to reflect minor growth potential in the anti-aging services market over the forecast period. The Asia-Pacific region has witnessed an exponential growth in the anti-aging services market due to the demand for cost-effective anti-aging services coupled with soaring disposable income. Besides, swiftly progressing medical tourism sector along with growing beauty consciousness in developing economies are estimated to increase growth opportunities in the lucrative markets of the Asia-Pacific region.

Browse Full Report with TOC at:

Anti-Aging Services Market Key Players

The global anti-aging services market has been dominated by key players such as Alma Lasers, Allergan Inc., Cynosure Inc., Beiersdorf AG, Elizabeth Arden, Cutera Inc., Estee Lauder Inc., Procter & Gamble, Lumenis, Solta Medical Inc., and others

Immunotherapy Drugs Market Share Current and Future Industry Trends 2017-2023

Immunotherapy Drugs Market Insight

The Global Immunotherapy Drugs Market has been inflating at an impressive rate in recent years. It is predicted that the market will expand further rapidly at a CAGR of 8.9 % by 2023, as per the reports presented by Market Research Future. The report also portrays that this Immunotherapy Drugs Market growth will maintain the same pace of growth by 2023 and will acquire a prominent place among competitors.

Immunotherapy Drugs are primarily used to enhance the immune system of the body. These drugs are mostly used in the treatment of cancer and act as a stimulator. Such stimulating action encourages the immune system of the body to generate an immune response, which eventually aids the production of antibodies. It is due to the incidence of cancer; the global immunotherapy market is predicted to inflate at a steady pace during the forecast period.

Global Immunotherapy Drugs Market

Immunotherapy is considered as an alternative to chemotherapy, which can also be used as a drug for cancer treatment. However, the increasing incidence of cancer is one of the significant factors which is driving global immunotherapy drugs market with opportunities for the market players, across the globe, to bring more chances of treatment for the cancer patients.

MRFR also includes in its report about particular statistics of deaths that occurred due to the most common cancers such lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer that were recorded and found as 16,90,000, 788,000, 774,000, 754,000, and 571,000 respectively in 2015.

As per the research, the global immunotherapy  drugs market is mainly driven by the growing adoption of targeted therapies and alteration of lifestyle, which is causing numerous diseases. With this, the support of rapid approval of drugs is propelling the market growth.

Immunotherapy is becoming one of the increasingly accepted treatments across the globe as the manufacturers are focusing on new approvals, collaborations, and development of new products. This is being practiced with the increase in demand for immunotherapy drugs for the treatment of cancer and other diseases. Such a high demand for products is also contributing highly to the global immunotherapy market to expand rapidly in the years to come.

On the flip side, factor such as high cost of treatments is expected to hinder the global immunotherapy market growth over the forecast period.

Immunotherapy Drugs Market Segmentation

According to MRFR’s reports, the Global Immunotherapy Drugs Market is segmented based on the therapy area, type of drugs, and end user.

In terms of therapy area, the market is segmented into cancer, autoimmune & inflammatory diseases, infectious diseases, and others.

In terms of the type of drugs, the market has been segmented into monoclonal antibodies, adult vaccines, checkpoint inhibitors, interferons alpha & beta, interleukins, and others.

In terms of end user, the market has been segmented into hospitals & clinics, ambulatory surgical centers, others.

Immunotherapy Drugs Market Regional Outlook

Geographically, the Global Immunotherapy Drugs Market has covered the main regions of the Americas, Europe, Asia Pacific, and The Middle East and Africa.

According to the research, the Americas and Europe are the chief contributors in the global immunotherapy drugs market owing to their reputation as a suitable region for research and development. The market for immunotherapy drugs has a huge demand in these regions and is probable to inflate with substantial CAGR in the years to come.

The Asia Pacific has been recorded to be the fastest growing immunotherapy drugs market owing to the existence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure in developing nations. With this, the increasing demand for new treatment methods in countries like India and South Korea are also likely to arise as the fastest growing market across the globe. The Middle East and Africa have recorded the least growth rate in comparison to other regions.

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

Immunotherapy Drugs Market Key Players

Here are the most prominent lists of market key players who are contributing to the Global Immunotherapy Market significantly. They are

  • Hoffmann-La Roche AG
  • GlaxoSmithKline
  • AbbVie, Inc.
  • Amgen, Inc.
  • Merck & Co., Inc.
  • Bristol-Myers Squibb
  • Novartis International AG
  • Eli Lilly and Company
  • Johnson & Johnson
  • AstraZeneca Plc

Immunotherapy Drugs Industry News

June 20, 2019:

Report says, the patients living with a specific type of leukemia will now have the opportunity from a new immunotherapy treatment on the NHS in England. Blincyto a drug used to treat adults with acute lymphoblastic leukemia has been recommended by the National Institute for Health and Care Excellence (NICE) for the patients.

Hair Removal Devices Market 2021 | Global Industry Analysis, Revenue, Key Players, Investment Feasibility and Forecast to 2023

Hair Removal Devices Market Overview: 

The global report on the hair removal devices market reveals that the market is expected to take a leap from its previous valuation of USD 915.2 million in 2017 with a 8.8% CAGR during the forecast period of 2018 to 2023. Market Research Future (MRFR) considers several factors like fashion, sports, cultural practices, military, medical reasons, and others as prominent growth-inducing avenues for the market. The easy availability of these products through retail and e-commerce lines strongly denotes hair removal devices market trends and better awareness regarding the product can boost the market prospect. 

Hair Removal Devices Market Segmentation: 

MRFR’s analysis of the global hair removal devices market leads to an in-depth segmentation of product and end-user. These segments have multiple inputs from various factors that help in gaining insights and developing better marketing strategies. 

By products, the global market for hair removal devices can be segmented into laser devices, intense pulse light (IPL) devices, energy-based devices, and others. The laser devices segment includes Nd: YAG laser, diode laser, and alexandrite laser. The laser devices segment had the maximum market share in 2017 and it is getting more traction from wider acceptance of the devices. The product is also performing better than other devices. 

By end-users, the global report on the hair removal devices market comprises beauty clinics, home use, dermatology clinics, and others. The beauty clinics segment had the largest market share in 2017 owing to its huge women customer base.

Hair Removal Devices Market Regional Analysis: 

The Americas is expected to make huge profit in the coming years in the hair removal devices market. This is primarily due to the high investment capacity, better disposable income standards, increasing launch of innovative products, and others. The US and Canada are performing better. In Europe, this growth would be backed by the growing sale in France, Germany, Italy, Spain, and the UK. In Asia Pacific, China, India, Japan, and South Korea are expected to boost the market traction.  

Hair Removal Devices Market Competitive Landscape: 

The global hair removal devices market growth can benefit substantially from various companies like Sciton, Inc, Alma Lasers, Ltd., Syneron Medical Ltd., Cutera Inc., Cynosure, Inc., Lynton Lasers Ltd, Solta Medical Inc., Strata Skin Sciences, Inc., Lumenis Ltd, Lutronic Corporation, and Venus Concept Canada Corp. These companies have done research works and have set their own growth policies to establish a strong outcome for themselves. The global market is slated to benefit from their mergers, acquisitions, collaborations, hike in research activities, better investment in research and development projects, and others are expected to steer the market towards innovations. MRFR recorded these recent moves to get their hands on various prospects in the coming days.

Browse Full Report with TOC at:

Hair Removal Devices Industry News: 

In April 2020, Aldi Australia announced that they would launch a new DIY or do-it-yourself hair removal gadget that promises salon-like experience. The product will be priced around USD90. It is supposed to hit the market in May. The company is trying to get hold of the market as the Australian government has banned all the beauty salons from functioning for the time being. 

On the other hand, IPL hair removal devices are losing grounds due to the COVID-19 pandemic outbreak. This is due to the lack in intake of the product that is happening all around the world. With lockdowns in motion, getting hair removal done from clinics and salons are now out of question, which led to a financial crisis. This crisis is impacting the intake.

Structural Heart Devices Market Analysis 2017-2023 by Global Trends, Development, Future Growth, Top Companies, Demand Forecast With Impact Analysis of COVID-19

Structural Heart Devices Market Scenario

The global structural heart devices market is predicted to demonstrate 10.4% CAGR during the forecast period (2018-2023) owing to the increasing frequency of structural heart diseases, asserts Market Research Future (MRFR). Structural heart disease is referred to the cardiac defects which are generally inherited by birth and are developed later in life, due to wear and tear from infection. The common structural heart diseases include ventricular septal defect, atrial septal defect, arterial/venous fistulae, paravalvular leak, congenital heart disease, and patent foramen oval. With advancements in the medical field, the open-heart surgical procedures have replaced with minimally invasive procedures like transcatheter mitral valve repair (TMVR) and transcatheter aortic valve replacement (TAVR).

Drivers and Constraints Impacting the Market

With the increasing prevalence of structural heart diseases, development of innovative repair devices like occluders and annuloplasty rings, technological advancements, and the growing demand for minimally invasive techniques, the global structural heart devices market is considered to propel during the assessment period. The increased focus of the key players on research and development activities of structural heart devices coupled with the upsurge in demand for long-lasting and quick procedures among the geriatric population are considered to offer lucrative opportunities for the players in the global market. Moreover, regulatory approvals of advanced and new structural heart devices, rising awareness about structural heart diseases, and favorable reimbursement scenario are likely to boost the market growth in the coming years.

On the flip side, high cost associated with the surgeries coupled with strict government mandates are some of the major concerns considered to dampen the global structural heart devices market growth during the appraisal period. Advanced products like sutureless heart valve cost higher than the earlier available products. The high price of sutureless devices will further limit the adoption of the equipment, thereby impeding the market growth during the forecast period.

Global Structural Heart Devices Market: Segmental Analysis

The global structural heart devices market has been segmented on the basis of indication, type, procedure, end-user, and region.

By mode of type, the global structural heart devices market has been segmented into occluders and delivery systems, heart valve devices, accessories, annuloplasty rings, and other devices. Among these, the heart valve devices are further sub-segmented into surgical heart valves and transcatheter heart valves. The surgical heart valves are sub-segmented into mechanical heart valves and tissue heart valves. Among these, the heart valve devices segment is considered to account for the largest market share owing to the increasing number of transcatheter aortic valve replacement procedures being performed across the world, growing number of regulatory approvals for heart valve devices, and durability and efficacy of these products.

By mode of indication, the global structural heart devices market has been segmented into cardiomyopathy, valvular heart disease, congenital heart defects, and others. Among these, the valvular heart disease has been further sub-segmented into stenosis and regurgitation.

By mode of procedure, the global structural heart devices market has been segmented into repair procedures and replacement procedures. Among these, the replacement procedures have been further sub-segmented into SAVR procedures and TAVR procedures. The repair procedures have been sub-segmented into annuloplasty, closure procedures, TMVR procedures and valvuloplasty. Among these, the replacement procedures segment is considered to hold the largest market share owing to the long-term durability of such procedures along with the widespread preference for transcatheter replacement.

By mode of end-users, the global structural heart devices market has been segmented into ambulatory surgery centers, hospitals, and others.

Structural Heart Devices Market Regional Insights

Geographically, the structural heart devices market span across regions namely, Europe, America, Asia-Pacific, and the Middle East & Africa.

Among all the regions, the American region is considered to lead the global structural heart devices market. The increasing rate of surgeries due to high blood pressure, diabetes, and other factors contribute to the growth of the market. Moreover, growing healthcare awareness, medical tourism, technological advancements, and rising disposable income are likely to fuel the market growth in this region.

Europe is considered to hold the second largest position in the global market as structural heart devices market is most prevalent in Germany. Moreover, the increasing geriatric population, rising prevalence of obesity and diabetes are influencing the market growth in this region.

The Asia Pacific region is considered to be the fastest growing region owing to the increasing patient population, growing elderly population, and changing lifestyle. Such factors are considered to offer favorable backgrounds to the market growth.

Browse Full Report with TOC at:

Structural Heart Devices Industry Updates

December 26, 2018: Keystone Heart is enrolling patients in the U.S. for a trial of its TriGuard 3 product, hoping for FDA approval in the third quarter of 2019. The company also expects to win the CE Mark approval for the device.

Structural Heart Devices Market Competitive Dashboard

The prominent players operating the global structural heart devices market are ST. Jude Medical, JenaValve Technology Inc., Comed BV, Boston Scientific Corporation (US), LivaNova plc (UK), Cook Group Incorporated (US), Biometrics, Edwards Lifesciences Corporation (US), Abbott (US), W. L. Gore & Associates Inc. (US), Medtronic plc (Ireland), CardioKinetix, and Endologix Inc. (US).

Hematology Diagnostics Market Analysis 2017-2023 by Future Growth With Impact Analysis of COVID-19, Revenue Analysis, Demand Forecast

Hematology Diagnostics Market Synopsis

Market Research Future (MRFR) speculates that the global hematology diagnostics market is predicted to demonstrate a robust CAGR during the forecast period (2018–2023) owing to the augmenting prevalence of blood disorders. Hematology is referred to as the branch of science which deals with the prognosis, cause, treatment, and prevention of blood disorders. Hematology diagnosis comprises the calculation of WBC, RBC, and platelets. It consists of the problems associated with RBC, WBC, lymph, bone marrow, and platelets. It comprises IVD technologies like flow cytometry, blood analysis, molecular diagnostics, immunodiagnostics, histology, hemostasis, and cytology.

Hematology Diagnostics Market Potential and Pitfalls

The augmenting prevalence of blood disorders coupled with technological advancements is considered to contribute to the hematology diagnostics market growth. Factors influencing the hematology diagnostics market are the rising incidences of genetic diseases, high adoption of hematology analyzers, increasing blood transfusions and donations, and rising hematological testing. As per the CDC and Prevention, around 70,000 to 100,000 of the Americans suffered from sickle cell disease in 2017, which is considered as a genetic blood disorder.

Automation is considered as one of the major areas of focus for hematology labs. Laboratories are extensively adopting automation for analytical, post-analytical, and pre-analytical steps in order to improve efficiency and also standardize the process. Processes such as processing, automation sample collection, test ordering, and test identification minimize the administrative errors besides facilitating reliable test results. Such factors are anticipated to contribute to the market growth to a large extent. Moreover, the increasing adoption of point-of-care (POC) hematology tests is presumed to influence the markeat growth as these tests are user-friendly and reduces the need for user-training.

On the contrary, poor healthcare insurance coverage for diagnosis, the high cost of diagnosis, and lack of awareness are some of the major concerns anticipated to slow down the market growth throughout the appraisal period.

Global Hematology Diagnostics Market: Segmental Analysis

The global hematology diagnostics market has been segmented on the basis of tests, product type, and end-user.

By mode of product type, the global hematology diagnostics market has been segmented into flow cytometers, hematology analyzers, and consumables. Among these, the hematology consumables segment is predicted to lead the global market owing to the increasing awareness of blood disorders among the patients and the healthcare professionals. Moreover, with the rising test volume due to the increasing awareness and early detection, the segment is considered to flourish.

By mode of tests, the global hematology diagnostics market has been segmented into hemoglobinopathy, anemia, hematology pathophysiology, leukemia/lymphoma phenotyping, complete blood count (CBC), and others.

By mode of end-users, the global hematology diagnostics market has been segmented into ambulatory surgical centers, hospitals and clinics, academic institutes, diagnostic laboratories, and others. Among these, the hospital’s segment is considered to dominate the global market. Diagnostic laboratories are predicted to expand at a rapid pace owing to the rising number of diagnostic centers coupled with the availability of advanced instruments.

Hematology Diagnostics Market Regional Insights

Geographically, the hematology diagnostics market span across regions namely, Europe, America, Asia-Pacific, and the Middle East and Africa.

Among all the regions, the North American region is predicted to dominate the global hematology diagnostics market and is likely to retain its dominance in the coming years. The growth is credited to the increasing prevalence of blood diseases in this region. As per Statista, 33% of all the Americans were diagnosed with hemophilia A in 2016. Factors contributing to the market growth are the presence of market giants like Bio-Rad Laboratories, Abbott Laboratories Danaher, and others coupled with the technological advancements and rising healthcare expenditure in this region.

The European region is predicted to occupy the second largest position in the global market owing to the rising hematology research in this region. For instance, the 16th World Hematology Congress will be conducted in London, in March 2019 in order to discuss the blood disorders, treatment, and diagnosis of hematology, hematologic disorders, hematologic oncology, and immunohematology.

The Asia Pacific region is anticipated to expand at the fastest rate due to the increasing prevalence of genetic diseases and blood disorders in this region.

Browse Full Report with TOC at:

Hematology Diagnostics Industry Updates

February 14, 2019: The ERBA Group, a leading global In-vitro diagnostic company, at their recently concluded MEDLAB expo, launched their latest hematology analyzers H 560 and H 360. They have been designed to improve the efficiency of the lab. With the emergence of these systems, better healthcare outcomes are penetrating the global market.

Hematology Diagnostics Market Competitive Dashboard

The prominent players operating the global hematology diagnostics market are BioSystems (Spain), Ortho Clinical Diagnostics (US), Abbott Laboratories (US), EKF Diagnostics (UK), Diatron (Hungary), Sysmex (Japan), Roche (Switzerland), Siemens (Germany), Boule Diagnostics (Sweden), Danaher (US), Mindray (China), Bio-Rad Laboratories (US), Drew Scientific (US), Nihon Kohden (Japan), HORIBA (Japan), and others.

RSV Diagnostics Market Analysis Reports Revenue Growth Globally During The Forecast Period 2017-2023

RSV Diagnostics Market Highlights

The latest report by Market Research Future (MRFR) states that the Respiratory Syncytial Virus (RSV) market is all set to gain substantial traction by accruing gigantic revenues by 2023. In addition, it is on track to surge at a CAGR of 10.4 % during the forecast period (2018–2023).

RSV Diagnostics Market Drivers and Top Restraints

The document named “Reducing Neonatal Mortality and Morbidity in Latin America And the Caribbean, An Interagency Strategic Consensus” states that almost 400,000 children under the age of five die due to infections that could have been prevented. This has attracted the focus of various health agencies that are striving to get a hold of the issue. For instance, Latin American Center for Perinatology and Pan America Health Organization (PAHO) have diverted their focus in the direction of educating the parents to fight against possible infections, promoting the growth of the RSV diagnostics market in the process.

The rising incidence rate of respiratory infections has done wonders for the market and is bound to surge at a significant rate in the coming years. with the growth in the incidences of chronic diseases around the world, there is bound to be an increase in the case of respiratory infections. This is going to have a definite positive impact on the demand for testing of infectious diseases like RSV. The deaths among neonates owing to these infections can be prevented when timely diagnosis and subsequent treatment is provided. Thus, the growing awareness regarding this factor is set to enhance the growth of the RSV diagnostics market in the years ahead.

The boost in the number of product launches across the globe will be one of the primary reasons fueling the growth of the respiratory syncytial virus diagnostics market in the forthcoming years. On that note, various diagnostics companies are keen on expanding their revenue with the development and introduction of the latest RSV diagnostics products in the market. These sophisticated diagnostic products are known to be highly efficient and reduce the time needed for the diagnosis.

The Rising Number of OEMs to be the Key Trend in the Global Market

The growth in the number of original equipment manufacturers (OEMs) is on its way to become a popular trend in the worldwide RSV diagnostics market in the near future. OEMs like Thermo Fisher Scientific and Sekisui Diagnostics are one of the leading manufacturers that offer RSV diagnostics.

There has been a rise in the number of combination products like drug delivery and smart devices, which is prompting the OEMs to work in conjunction with the contract manufacturing organizations (CMOs), making way for a number of new companies to gain entry into the market. As a result, there has been an increase in the product range required for diagnosing RSV. 

RSV Diagnostics Market Segmentation

The global RSV diagnostics market has been segmented based on product, method, and end-user.

Depending on the type of product, the market has been classified into kits and assays, instruments, and other products.

Method-wise, the global RSV diagnostics market has been considered for molecular diagnostics, rapid antigen detection test, gel microdroplets, flow cytometry, and others. Furthermore, the rapid antigen detection tests are sub-segmented into enzyme-linked immunosorbent assays, immunofluorescence assays, and other rapid antigen detection tests. The other type of rapid antigen detection tests can be segmented into chromatographic immunoassays and optical immunoassays.

The end-users mentioned in the report include hospitals and clinics, clinical laboratories, home care, and others.

RSV Diagnostics Market Regional Outlook

The global RSV diagnostics market is segmented into the regional markets of the Americas, Asia Pacific, Europe, as well as the Middle East & Africa.

The Americas will be the most lucrative market for RSV diagnostics on account of the rising incidences of RSV, growing healthcare expenditure and technological advancements in molecular diagnostics. As per the Centers for Disease Control and Prevention, over 57,000 children younger than five years old are hospitalized owing to RSV infection every year, in the United States (U.S). In order to bring down this abysmal number, various initiatives and programs are being introduced in the region, which means that the market will be doing excellent business in the region in the years to come.

Meanwhile, Europe has landed the second spot in the global RSV diagnostics market, with factors like increasing automation in vitro diagnostics, rising occurrence of RSV diseases, and surging funding offered by the government backing the said growth. Considering the current status of the region, the data furnished by the University of Oxford states that more than 30,000 babies and children less than five years of age are expected to be hospitalized every year owing to RSV.

The RSV diagnostics market in Asia Pacific can be broken down into smaller markets in the countries of India, Japan, China, Republic of Korea, Australia and the rest of the region. The regional market is touted to be the fastest-growing globally as a result of the rise in the infectious disease which includes the RSV infection. Also, the increasing healthcare expenditure coupled with the surge in the demand for RSV disease diagnosis has taken the market to higher levels in the past few years. In addition, countries like India, China, and Japan are deemed to be growing at the fastest rate in the region with the expanding healthcare systems along with the growing government initiatives backing up these markets.

Showcasing a rather sluggish growth rate in the global market is the region of the Middle East and Africa, which despite various restraints holds immense potential. The market shows promise, with the support of various factors including the increasing awareness and high investments by private industry participants combined with the increasing incidences of RSV in children in the region. 

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

RSV Diagnostics Market Key Vendors

Bio-Rad Laboratories Inc., Abbott, F. Hoffman-La Roche Ltd., Danaher Corporation, Quest Diagnostics, Biocartis, Luminex, Hologic, Fast Track Diagnostics, Biomerieux, Becton, Dickinson, and Company (BD), Alere, Inc., Quidel Corporation, Thermo Fisher Scientific are among some of the top most companies in the RSV diagnostics market.

RSV Diagnostics Industry Latest News

May 2019: SpeeDx Pty. Ltd. has gotten the clearance from the Australian Therapeutic Goods Administration (TGA) of their PlexPCR RespiVirus test. It makes use of the PlexPCR technology for detecting 11 types of pathogens known for causing viral respiratory-illnesses. In addition, this test also lets the laboratories process a greater number of samples in a limited period of shift compared to a conventional in-house test.

Infection Control Market Growth Factors, Share, Trends, Regional Analysis, And Key Country Outlook To 2023

Infection Control Market Scenario

Market Research Future (MRFR) expects the global infection control market to rise at a CAGR of close to 7.5% during the forecast period (2017-2023).

Growth Drivers and Top Barriers

The infection control market gets a boost from the rise in surgical procedures requiring high-intensity infection prevention. The growing preference is believed to be the result of positive clinical outcomes linked with the use of infection control.

The hike in the number of government initiatives with the aim of infection prevention is thought to be the chief factor driving the market. Furthermore, government organizations are progressively issuing guidelines for promoting awareness about efficient prevention measures worldwide. This is a crucial factor expected to work in favor of the market.

World Health Organization (WHO) deems Acute Respiratory Diseases (ARDs) as one of the significant causes leading to death across the globe. Roughly 4.0 million deaths are caused by ARDs every year. These numbers exemplify the rising need for strict prevention as well as control. It is predicted that prolonged hospital stay is uneconomical for hospitals as well as healthcare payers with the excessive use of resources for treating acquired infections. These extra costs are mostly generated with the high usage of drugs, laboratory equipment, additional diagnostic studies, which leads to resource allocation imbalance. This factor has accelerated the demand for infection control market across the globe and is expected to increase further in the following years.

Infection Control Market Segmentation

The worldwide market for infection control has been segmented on the basis of type and end-user.

Type-wise, the infection control market is considered for disinfection products, sterilization products and services, and others. The disinfection product includes disinfectants, medical nonwovens, disinfectors, and endoscope reprocessors.

The end-users in the global infection control market are hospitals and clinics, life sciences industry, medical device companies, pharmaceutical companies, food industry, and others.

Infection Control Market Regional Insight

The main markets for infection control market are Europe, America, Middle East & Africa, and Asia Pacific.

The Americas is believed to rise as the most lucrative infection control market backed by the rising awareness about chronic infections combined with the surging number of service providers. The United States (U.S.) covers the maximum share of the regional market for infection control on account of the presence of sophisticated healthcare infrastructure and highly developed medical technologies.

It is quite likely that Europe could emerge as the second leading market for infection control. The presence of developed research and development facilities along with a slew of technological advancements is expected to fetch excellent revenues during the evaluation time frame.

The Asia Pacific market can expect the fastest growth during the review period with the surge in healthcare expenditure and superlative healthcare standards and infrastructure. Also, the boost in the number of outsourcing organizations in the region will benefit the market in the forthcoming years. For example, a voluntary organization known as Asia Pacific Society of Infection Control (APSIC) indulge in collaborations and partnerships as well as infection control researches to promote cost-efficient practices throughout the region. The regional market also gains momentum on the back of various government organizations committed to elevating the standards for infection control.

Middle East and Africa is perceived to develop steadily in the coming years based on the extensive advancement of the healthcare infrastructure coupled with the rising R&D activities within the healthcare sector.

Infection Control Market Key Participants

The esteemed players shaping the worldwide infection control market include Honeywell International, Inc. (U.S.), Cantel Medical Corporation (U.S.), Ahlstrom Corporation (Finland), STERIS Corporation (U.K.), Getinge Group (Sweden), MMM Group (Germany), Advanced Sterilization Products (U.S.), Ecolab (U.S.), Belimed AG (Switzerland), Sotera Health (U.S.), Metrex Research (U.S.), Reckitt Benckiser (U.K.), Matachana (Spain), 3M Healthcare Company (U.S.), Halyard Health (U.S.), Pal Internation (U.K.), Nordion, Inc. (U.S.), to name a few.

Browse Full Report with TOC at:

Infection Control Industry Latest News

June 2019: Medline has launched its first infection control product, Micro-Kill Bleach Germicidal Bleach Wipes, after getting clearance from EPA. This product is highly efficient in disinfecting hospital surfaces, which is home to C. Auris, an infection causing fungus.

Drug Allergy Market Inclinations & Development Status Highlighted During Forecast Period 2018-2023 | Impact of COVID-19 Pandemic

Drug Allergy Market Synopsis

The current report by Market Research Future (MRFR) asserts that the global drug allergy market 2020 is slated to acquire a substantial market valuation of USD 4.7 billion by 2023, at a moderate 5.1% CAGR over the review period.

Drug Allergy Market Drivers and Restraints

Growing awareness about numerous allergies, the introduction of the new treatment of products, and growing demand from developing markets drive the growth of the global market. Further research to prevent drug allergies is another crucial driver for the market. The global drug allergy market is increasing moderately and is anticipated to continue its growth over the forecast period.

Drug Allergy Market Segmentation

The global drug allergy market is analyzed on the basis of type, which comprises of nonimmunologic, immunologic, and others. Immunologic allergy is sub-segmented into type II reaction, type IV reaction, type I reaction, type III reaction, and others. The non-immunologic allergy is sub-segmented into unpredictable, predictable, and others. The predictable allergy is further segmented into secondary pharmacologic side effects, pharmacologic side effects, drug toxicity, drug overdose, drug-drug interactions, and others. The unpredictable segment is further sub-segmented into idiosyncratic, pseudoallergic, intolerance, and others.

On the basis of diagnosis, the drug allergy market is segmented into blood tests, skin tests, patch tests, and others. The skin test is further segmented into the intradermal test, prick or scratch test, and others.

On the basis of treatments, the drug allergy market is segmented into corticosteroids, antihistamines, withdrawal of the drug, treatment of anaphylaxis, and others. Antihistamines are further sub-segmented into azelastine nasal sprays, cyproheptadine, carbinoxamine, desloratadine, emedastine eyedrops, diphenhydramine, hydroxyzine, levocabastine oral, azelastine eyedrops, levocabastine eyedrops, and others. Corticosteroids is further sub-segmented into inhaled steroids, topical steroids, and others. Inhaled steroids are further segmented into flunisolide, fluticasone propionate, fluticasone furoate, triamcinolone acetonide, budesonide, beclomethasone dipropionate, and others.

On the basis of end-user, the market is segmented into medical research centers, hospitals & clinics, academic institutes, and others.

Drug Allergy Market Regional Overview

The geographical overview of the global drug allergy market has been conducted in four major regions, specifically North America, Europe, the Asia Pacific, and the rest of the world (including Latin America and the Middle East and Africa).

The Americas lead the global market for drug allergy. The Americas mainly include Latin America and North America, out of which North America accounts for the maximum market share of this region. The US is the top revenue-generating market in North America and is one of the critical markets for global drug allergy treatment. Approximately 10% of the total US population has drug allergies. Latin America’s drug allergy market is also growing significantly and mainly includes Brazil, Argentina, and Chile. Europe is the second-largest market in the globe owing to increasing cases of drug allergy.

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

Europe is primarily divided into Eastern Europe and Western Europe. More developed Western European countries like UK, Germany, and France are leading this market while the East European region is also rising significantly. Growing cases of drug allergies are one of the substantial factors for the progress of the European market.

Asia Pacific region is experiencing the fastest growth rate in the global drug allergy market due to some significant factors such as availability of treatment products, increasing awareness about various drug allergies, and rapidly improving healthcare facilities. Japan is holding a noteworthy market share, while China’s drug allergy market is anticipated to show the fastest growth in this region. Varying healthcare practices and growing patient involvement play a vital role in the expansion of this market.

The Middle East & Africa is anticipated to witness limited growth due to a lack of awareness about diseases, traditional healthcare practices, among others. The Middle East region leads the regional market due to some of the significant factors, such as the developed healthcare facilities and government support to improve public health.

Drug Allergy Market Competitive Landscape

The top market players identified by MRFR in the global market are Bayer (US), AstraZeneca (UK), Circassia (US), Johnson & Johnson Services, Inc. (US), HAL Allergy Group (the Netherlands), Stallergenes Greer (UK), MAGNA Pharmaceuticals, Inc. (US), and others.

Superdisintegrants Market : Business overview, Upcoming Trends and Top Company Analysis Forecast By 2023 | Impact of COVID-19 Pandemic

Superdisintegrants Market Synopsis

Market Research Future (MRFR) speculates that the global Superdisintegrants market is slated to garner USD 576.2 million, grabbing a CAGR of 7.9% during the forecast period (2018 to 2023). Increased production of generic drugs is predicted to is estimated to favor the market growth in the coming years. Disintegrants are referred to as substances which are generally included in drug formula in order to allow proper disintegration of the tablet or capsule into dissolvable particles. Superdisintegrants are added to drug formulation to facilitate the dissolution of the capsule content into reduced particles. Crospovidone, sodium starch glycolate, and croscarmellose sodium are some of the widely used products.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @

Superdisintegrants Market Potential and Pitfalls

The pharmaceutical sector is observed to grow at a breakneck and is becoming an important part of the healthcare sector owing to the increasing population of both pediatric as well as geriatric patients. Superdisintegrants help to treat patients of this demographic as these tablets can be swallowed easily. With the growth of the demographic, the market for Superdisintegrants is estimated to flourish. Generic drugs are also high in demand as patents are running out on popular drug brands, thereby opening up the pharmaceutical sector for rising entry of competition and increased manufacturing of generic drugs. This has further propelled the market demand for superdisintegrants across the globe.

Superdisintegrants are extensively used in the production of drugs aimed at pediatric and geriatric patients as they provide good efficacy and disintegration at low dosage. With the rising incidences of several chronic diseases coupled with the rapidly growing healthcare infrastructure, the market is considered to propel. Governments from several economies are focusing on prevention rather than treatment, which has triggered the consumption of pharmaceuticals, thereby fostering the market growth. Moreover, advanced R&D activities is contributing to the growth of the market. For instance, substances like gellan gum, soy polysaccharide, isapghula husk mucilage, karaya gum, and locust bean gum are some of the natural substances which can be used as superdisintegrants in solid dosage form.

On the contrary, lack of investment in research and development activities is predicted to deter the Superdisintegrants market throughout the appraisal period.

Global Superdisintegrants Market: Segmental Analysis

The global Superdisintegrants market has been segmented on the basis of formulation, type, and therapeutic area.

By mode of type, the global Superdisintegrants market has been segmented into natural disintegrants, synthetic superdisintegrants, and others. Among these, the synthetic Superdisintegrants occupies a major share as they are widely used in the formulation of drugs. On the other hand, natural Superdisintegrants are expanding at a rapid pace owing to the increased demand for natural ingredients.

By mode of formulation, the global Superdisintegrants market has been segmented into tablets and capsules. Among these, the tablets command a major share as they are easy to consume.

By mode of therapeutic area, the global Superdisintegrants market has been segmented into neurological diseases, gastrointestinal diseases, infectious diseases, oncology, hematological diseases, inflammatory diseases, and cardiovascular diseases. Among these, the gastrointestinal diseases occupy a major share owing to the demand for fast acting medicine for such kinds of diseases.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ 

Superdisintegrants Market Regional Insights

Geographically, the Superdisintegrants market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.

Among all the regions, the American region is considered go capture the largest market share, led by the U.S. The growth is credited to the presence of a well-developed healthcare infrastructure and prominent market players. Moreover, due to the rising prevalence of chronic diseases, the demand for drugs where superdisintegrants are required have increased, thereby influencing the market.

The Asia Pacific region is predicted to expand at the highest pace owing to the high concentration of rapidly emerging markets in this region. Country-level markets like India, China, and Japan have a high demand for drugs due to increased prevalence of chronic diseases. Moreover, with the presence of contract manufacturing organizations for pharmaceuticals and rapidly growing healthcare sector, the market for Superdisintegrants is considered to foster.

Superdisintegrants Market Competitive Dashboard

The prominent players operating the global Superdisintegrants market are Ashland Global Holdings Inc., Avantor Performance Materials LLC, Corel Pharma Chem, Roquette Freres, Asahi Kasei Corporation, Merck KGaA, JRS Pharma, BASF SE, DowDuPont Inc., and DFE Pharma.

Influence Of COVID-19 On Medical Writing Market Projected to Discern Stable Expansion During 2020 to 2025

Medical Writing Market Overview: 

The global medical writing market has evolved exponentially with the expansion of the pharmaceutical and biotechnology industries. The use of medical writing is extensive in pharmaceutical & biotechnology companies. Moreover, the burgeoning CRO industry fosters the growth of the market. With the increase in patent expiration, the need to draft new patents is growing too, which, as a result, drives the medical writing market. Cumulatively led by these factors, the global medical writing market valuation is expected to cross USD 3.25 BN by 2025 at a CAGR of 10.1 % during 2019-2025.

Medical Writing Market Major Players: 

Key players leading the global medical writing market include Freyr Solutions (US), Parexel International Corporation (US), Cactus Communications (UK), IQVIA (US), Covance Inc. (US), OMICS International (India), SIRO CLINPHARM (India), SYNCHROGENIX (US), INCLIN, (US), and Clinexa Life Sciences Pvt (Australia), among others. 

Medical Writing Market Drivers & Restraints 

Medical writing comprises scripting of diverse scientific information, preparing regulatory paperwork, and publication of documents related to drug discovery, clinical trials, and several other written communication work intended for regulatory bodies, health care providers, researchers, the general public, etc.

Medical writing requires medical knowledge and understanding of drug development and regulatory guidelines. It plays a vital role in the success of various clinical trials and research projects. It is quite challenging to handle pre-approval regulatory writing, develop a scientific platform & publication plan, promotional & educational materials, all at once by a single company. Hence, this medical writing has been the preferred model for quite some time now. 

Hiring a medical writing vendor benefits, not just the pharmaceutical companies but also to the patients and society ultimately. Resultantly the global medical writing market has been making quite a stride over the last few years. Increasing demand for regulatory paperwork in the pharmaceutical and biopharmaceutical industry is a significant driving force behind the growth of the market. Besides, rising patent expiration has been leading to increasing the demand for medical writers in recent years.

Substantial investments made in the rising numbers of research and development activities in the pharma & biotechnology industries are directly linked to the growth of the market. As various companies and government bodies are investing in R&D of clinical trials, the demand for clinical writing is increasing. Also, medicines are becoming more complex nowadays, and the pharmaceutical industry is becoming increasingly focused on their core competency of drug discovery.  

Consecutively, pharma companies are getting heavily reliant on outsourced partners for non-core capabilities, such as medical writing. The increased reliance in terms of strong, highly credentialed, and responsive service providers to assist with the publication, regulatory, and promotional strategies offers an exciting opportunity for the medical writing industry. However, factors such as stringent government regulatory policies are restraining the growth of the market. 

Medical Writing Market – Segments

The Medical Writing Market report has been segmented into four major dynamics.

By Type: Clinical Writing, Scientific Writing, Regulatory Writing, Disease & Drug-Related Writing, and others.

By Application : Medical Education, Medical Journalism, Medico Marketing, and others.

By End User: Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS), and others.

By Regions: Americas, Europe, Asia Pacific, Middle East & Africa, and Rest-of-the-World.

Global Medical Writing Market – Regional Analysis

North America accounts for the largest share in the global medical writing market, attributing to the well-developed healthcare, pharmaceutical, and biotechnology industries. The presence of major players and pharma & biotechnology companies foster the market growth excellently. Moreover, increasing the consumption of medicines, medical devices, and other pharmaceutical products drive the growth of the regional market.

Furthermore, substantial investments made in the discovery and development of various drugs and medical products impact the market growth positively. Also, rising numbers of researches in biotechnology alongside the burgeoning CRO industry substantiate the growth of the regional market. The North American medical writing market is expected to grow at a substantial CAGR over the forecasted period.

Europe is another lucrative market for medical writing. The presence of some of the best healthcare services propels the growth of the regional market. Moreover, the growth of the healthcare industry and the expansion of various biopharmaceutical industries in the region create a massive demand for medical writing. Indeed, the resurging economy in the region is a dominant factor substantiating the market growth, increasing the healthcare and pharmaceutical industries.

The market size is increasing with the augmenting demand for CMOs and CTOs. Also, increasing government funding initiated to increase the numbers of R&D activities for the drug discoveries, provides impetus to the regional market growth. The European medical writing market is expected to grow at a considerable CAGR over the assessment period.

The medical writing market in the Asia Pacific region is emerging as a profitable market. The region has the world’s largest population and fast-developing healthcare industry. The rapidly growing pharma industry, alongside the healthcare industry, fosters the market growth in the region. Besides, the availability of skilled professional and cost-competitive services allows the region to have the edge over other regions. The APAC medical writing market is expected to grow at a rapid rate during the forecasted period. 

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Medical Writing Market – Competitive Analysis

Highly competitive, the medical writing market appears to be well-established, with many players forming a competitive landscape. The competitive strength of these players is highly dependent on service precision, service pricing, versatility, and service reliability. Service providers operating in the medical writing market strive to offer quality services that are based on best practices. 

Medical Writing Industry/ Innovation /Related News: 

January 23, 2020 —- Nuvisan Pharma Services GmbH & Co KG (Germany), a leading global CRO/CDMO, announced the acquisition of Inamed GmbH (Germany), an international Contract Research Organization (CRO). Nuvisan Pharma provides pharmaceutical research services while Inamed is specialized in clinical trials with patients living with respiratory and rare diseases.

Inamed offers a wide range of clinical trial and related services, such as medical writing, project management, and others. Over the last several years, Nuvisan and Inamed have worked together, collaborating on a number of services. The merger is the logical next step in this long-lasting, successful cooperation.

Create your website at
Get started